|
1
|
Friedenreich CM, Shaw E, Neilson HK and
Brenner DR: Epidemiology and biology of physical activity and
cancer recurrence. J Mol Med (Berl). 95:1029–1041. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Benson AB III, Venook AP, Cederquist L,
Chan E, Chen YJ, Cooper HS, Deming D, Engstrom PF, Enzinger PC,
Fichera A, et al: Colon Cancer, version 1.2017, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw.
15:370–398. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wiltshire HR, Kilpatrick GJ, Tilbrook GS
and Borkett KM: A placebo- and midazolam-controlled phase I single
ascending-dose study evaluating the safety, pharmacokinetics, and
pharmacodynamics of remimazolam (CNS 7056): Part II. Population
pharmacokinetic and pharmacodynamic modeling and simulation. Anesth
Analg. 115:284–296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wehrmann T and Triantafyllou K: Propofol
sedation in gastrointestinal endoscopy: A gastroenterologist's
perspective. Digestion. 82:106–109. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pearlman R, Frankel WL, Swanson B, Zhao W,
Yilmaz A, Miller K, Bacher J, Bigley C, Nelsen L, Goodfellow PJ, et
al: Ohio Colorectal Cancer Prevention Initiative Study Group:
Prevalence and spectrum of germline cancer susceptibility gene
mutations among patients with early-onset colorectal cancer. JAMA
Oncol. 3:464–471. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Allenson K, Castillo J, San Lucas FA,
Scelo G, Kim DU, Bernard V, Davis G, Kumar T, Katz M, Overman MJ,
et al: High prevalence of mutant KRAS in circulating
exosome-derived DNA from early-stage pancreatic cancer patients.
Ann Oncol. 28:741–747. 2017.PubMed/NCBI
|
|
8
|
Logtenberg S, Oude Rengerink K, Verhoeven
CJ, Freeman LM, van den Akker E, Godfried MB, van Beek E, Borcher
O, Schuitemaker N, van Woerkens E, et al: Labour pain with
remifentanil patient-controlled analgesia versus epidural
analgesia: A randomised equivalence trial. BJOG. 124:652–660. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Manjelievskaia J, Brown D, McGlynn KA,
Anderson W, Shriver CD and Zhu K: Chemotherapy use and survival
among young and middle-aged patients with colon cancer. JAMA Surg.
152:452–459. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaminski MF, Thomas-Gibson S, Bugajski M,
Bretthauer M, Rees CJ, Dekker E, Hoff G, Jover R, Suchanek S,
Ferlitsch M, et al: Performance measures for lower gastrointestinal
endoscopy: A European Society of Gastrointestinal Endoscopy (ESGE)
quality improvement initiative. Endoscopy. 49:378–397. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bisschops R, Areia M, Coron E, Dobru D,
Kaskas B, Kuvaev R, Pech O, Ragunath K, Weusten B, Familiari P, et
al: Performance measures for upper gastrointestinal endoscopy: A
European Society of Gastrointestinal Endoscopy quality improvement
initiative. United European Gastroenterol J. 4:629–656. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Frölich MA, Banks C and Ness TJ: The
effect of sedation on cortical activation: A randomized study
comparing the effects of sedation with midazolam, propofol, and
dexmedetomidine on auditory processing. Anesth Analg.
124:1603–1610. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eleveld DJ, Proost JH, Vereecke H, Absalom
AR, Olofsen E, Vuyk J and Struys MMRF: An allometric model of
remifentanil pharmacokinetics and pharmacodynamics. Anesthesiology.
126:1005–1018. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kisilewicz M, Rosenberg H and Vaillancourt
C: Remifentanil for procedural sedation: A systematic review of the
literature. Emerg Med J. 34:294–301. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Porter-Stransky KA, Bentzley BS and
Aston-Jones G: Individual differences in orexin-I receptor
modulation of motivation for the opioid remifentanil. Addict Biol.
22:303–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Scott HB, Choi SW, Wong GTC and Irwin MG:
The effect of remifentanil on propofol requirements to achieve loss
of response to command vs. loss of response to pain. Anaesthesia.
72:479–487. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dumans-Nizard V, Le Guen M, Sage E, Chazot
T, Fischler M and Liu N: Thoracic epidural analgesia with
levobupivacaine reduces remifentanil and propofol consumption
evaluated by closed-loop titration guided by the bispectral index:
A double-blind placebo-controlled study. Anesth Analg. 125:635–642.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Weiniger CF, Carvalho B, Stocki D and
Einav S: Analysis of physiological respiratory variable alarm
alerts among laboring women receiving remifentanil. Anesth Analg.
124:1211–1218. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aaronson J, Abramovitz S, Smiley R, Tangel
V and Landau R: A survey of intravenous remifentanil use for labor
analgesia at academic medical centers in the United States. Anesth
Analg. 124:1208–1210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shafer SL and Fisher DM: Remifentanil
dosing at extremes of body weight. Anesthesiology. 126:993–994.
2017. View Article : Google Scholar : PubMed/NCBI
|
